The primary objective of this predoctoral National Research Service Award program in Pharmacological Sciences is to develop scientists equipped with the necessary background in the basic biological and physical sciences, and training in the application of modern tools of research and instrumental techniques of the physical and biological sciences, to undertake and direct fundamental research related to drug action, metabolism and kinetics. These aspects include mechanisms by which drugs produce their effects on organisms and also the effects of biological systems on drugs, including the areas of drug distribution, bioavailability, metabolic processes, elimination and the study of kinetics of these processes. The training program would support Ph.D. student sin the broadly defined areas of drug metabolism, pharmacokinetics, cellular pharmacology and molecular pharmacology which presently exists in the departments of Medicinal Chemistry, Pharmaceutics and Pharmacology. Didactic components involved individualized, highly multi-disciplinary programs of coursework and seminars which involve the biological, chemical, spectroscopic and mathematical sciences. Research components of the training program will focus on the areas of the application and may involve collaborative research with other departments in the University. In this request for continuation of the Pharmacological Sciences National Research Service Award program, support is requested for 18 predoctoral trainees in the first year, 20 trainees in the third year and in subsequent years. The selection of trainees will be on a competitive basis primarily among second year or more advanced graduate students who are committed to research in one of these areas of the application.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007750-23
Application #
6350993
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Preusch, Peter C
Project Start
1979-07-01
Project End
2004-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
23
Fiscal Year
2001
Total Cost
$452,030
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Abraham, Antony D; Schattauer, Selena S; Reichard, Kathryn L et al. (2018) Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion. J Neurosci 38:8031-8043
Kraft, John C; McConnachie, Lisa A; Koehn, Josefin et al. (2018) Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation. J Control Release 275:229-241
Goulet, Dennis R; Orcutt, Steven J; Zwolak, Adam et al. (2018) Kinetic mechanism of controlled Fab-arm exchange for the formation of bispecific immunoglobulin G1 antibodies. J Biol Chem 293:651-661
Rubinstein, M; Patowary, A; Stanaway, I B et al. (2018) Association of rare missense variants in the second intracellular loop of NaV1.7 sodium channels with familial autism. Mol Psychiatry 23:231-239
Lee, Nora; Hebert, Mary F; Wagner, David J et al. (2018) Organic Cation Transporter 3 Facilitates Fetal Exposure to Metformin during Pregnancy. Mol Pharmacol 94:1125-1131
Aliwarga, Theresa; Evangelista, Eric A; Sotoodehnia, Nona et al. (2018) Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes. Int J Mol Sci 19:
Wagner, David J; Shireman, Laura M; Ahn, Sojung et al. (2018) Disposition of Methamphetamine and Major Metabolites in Mice: Role of Organic Cation Transporter 3 in Tissue-Selective Accumulation of Para-Hydroxymethamphetamine. Drug Metab Dispos 46:1277-1284
Gao, Yu; Kraft, John C; Yu, Danni et al. (2018) Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy. Eur J Pharm Biopharm :
Wong, Timothy; Wang, Zhican; Chapron, Brian D et al. (2018) Polymorphic Human Sulfotransferase 2A1 Mediates the Formation of 25-Hydroxyvitamin D3-3-O-Sulfate, a Major Circulating Vitamin D Metabolite in Humans. Drug Metab Dispos 46:367-379
Abraham, Antony D; Fontaine, Harrison M; Song, Allisa J et al. (2018) ?-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition. Neuropsychopharmacology 43:362-372

Showing the most recent 10 out of 149 publications